Evidence map›Paper›PMID 28414759›Full record

ArticlePloS one2017

Significant association of RNF213 p.R4810K, a moyamoya susceptibility variant, with coronary artery disease.

Takaaki Morimoto, Yohei Mineharu, Koh Ono, Masahiro Nakatochi, Sahoko Ichihara, Risako Kabata, Yasushi Takagi, Yang Cao, Lanying Zhao, Hatasu Kobayashi and 10 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 1 pooled it
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 1 synthesis or guideline pooled it, 80 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Peripheral bloodStroke and vascular neurology · 2025
    Article
  4. Review
  5. Genes · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Brain communications · 2025
    Article
  13. ExploringBiomedicines · 2024
    Review
  14. Article
  15. Article
  16. JACC. Asia · 2023
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 8 institutions in 1 country.

Takaaki MorimotoDepartment of Neurosurgery, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Yohei MineharuDepartment of Neurosurgery, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Koh OnoDepartment of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Masahiro NakatochiStatistical Analysis Section, Center for Advanced Medicine and Clinical Research, Nagoya University Hospital, Nagoya, Japan.
Sahoko IchiharaGraduate School of Regional Innovation Studies, Mie University, Tsu, Japan.
Risako KabataDepartment of Health and Environmental Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Yasushi TakagiDepartment of Neurosurgery, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Yang CaoDepartment of Health and Environmental Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Lanying ZhaoCongenital Anomaly Research Center, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Hatasu KobayashiDepartment of Health and Environmental Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Kouji H HaradaDepartment of Health and Environmental Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Katsunobu TakenakaDepartment of Neurosurgery, Takayama Red Cross Hospital, Gifu, Japan.
Takeshi FunakiDepartment of Neurosurgery, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Mitsuhiro YokotaDepartment of Genome Science, School of Dentistry, Aichi Gakuin University, Nagoya, Japan.
Tatsuaki MatsubaraDepartment of Internal Medicine, School of Dentistry, Aichi Gakuin University, Nagoya, Japan.
Ken YamamotoDepartment of Medical Biochemistry, Kurume University School of Medicine, Fukuoka, Japan.
Hideo IzawaDepartment of Cardiology, Fujita Health University, Banbuntane Hotokukai Hospital, Nagoya, Japan.
Takeshi KimuraDepartment of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Susumu MiyamotoDepartment of Neurosurgery, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Akio KoizumiDepartment of Health and Environmental Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Kyoto University · JPAichi Gakuin University · JPFujita Health University · JPKurume University Medical Center · JPMie University · JPNagoya University Hospital · JPSt. Marianna University School of Medicine · JPTakayama Red Cross Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe genetic architecture of coronary artery disease has not been fully elucidated, especially in Asian countries. Moyamoya disease is a progressive cerebrovascular disease that is reported to be complicated by coronary artery disease. Because most Japanese patients with moyamoya disease carry the p.R4810K variant of the ring finger 213 gene (RNF213), this may also be a risk factor for coronary artery disease; however, this possibility has never been tested. METHODS AND

resultsWe genotyped the RNF213 p.R4810K variant in 956 coronary artery disease patients and 716 controls and tested the association between p.R4810K and coronary artery disease. We also validated the association in an independent population of 311 coronary artery disease patients and 494 controls. In the replication study, the p.R4810K genotypes were imputed from genome-wide genotyping data based on the 1000 Genomes Project. We used multivariate logistic regression analyses to adjust for well-known risk factors such as dyslipidemia and smoking habits. In the primary study population, the frequency of the minor variant allele was significantly higher in patients with coronary artery disease than in controls (2.04% vs. 0.98%), with an odds ratio of 2.11 (p = 0.017). Under a dominant model, after adjustment for risk factors, the association remained significant, with an odds ratio of 2.90 (95% confidence interval: 1.37-6.61; p = 0.005). In the replication study, the association was significant after adjustment for age and sex (odds ratio = 4.99; 95% confidence interval: 1.16-21.53; p = 0.031), although it did not reach statistical significance when further adjusted for risk factors (odds ratio = 3.82; 95% confidence interval: 0.87-16.77; p = 0.076).

conclusionsThe RNF213 p.R4810K variant appears to be significantly associated with coronary artery disease in the Japanese population.

Indexed as

Adenosine TriphosphatasesAgedAged, 80 and overAmino Acid SubstitutionAsian PeopleCase-Control StudiesCoronary Artery DiseaseFemaleGenetic Predisposition to DiseaseHumansJapanMaleMiddle AgedMoyamoya DiseasePolymorphism, Single NucleotideRisk FactorsAdenosine TriphosphatasesRNF213 protein, humanUbiquitin-Protein Ligases

Identifiers

PMID28414759
PMCPMC5393571
OpenAlexW2606623729

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.